Navigation Links
Texas Back Institute Leads Way in New Facet Joint Clinical Trial
Date:11/6/2008

TBI is first and only participant in Texas for TFAS spinal implant

PLANO, Texas, Nov. 6 /PRNewswire/ -- Texas Back Institute is leading the way again in motion preserving technology by continuing to advance spinal device studies with a clinical trial of the Total Facet Arthroplasty System (TFAS)(R).

Dr. Barton Sachs of Texas Back Institute performed the TFAS procedure on Ron Kaipus in September 2006. The Richardson, Texas resident was one of the first 40 people worldwide to receive TFAS. He is now back on the golf course and enjoying his life to the fullest. At age 67, he doesn't miss a beat and is grateful for being virtually pain-free. "I'm back to my old self," said Kaipus. "It truly gave me my life back. I'm so thankful I was able to be a part of the trial."

TFAS is a spinal implant intended for the treatment of patients with chronic leg and/or back pain caused by spinal stenosis. It's part of a category of treatment devices intended to stabilize affected spinal joints while preserving the natural motion of the spine.

"It's a great device because it frees up the nerves and spinal cord, eliminates the excess bone growth and maintains natural motion," said Dr. Sachs. "Patients are recovering quickly and we've seen excellent results so far. We're excited about the future of the trial."

There are openings within the clinical trial and Dr. Sachs explained that patients affected with spinal stenosis or spondylolisthesis should investigate this unique opportunity with Texas Back Institute.

Texas Back Institute is no stranger to motion preservation spinal technology. It pioneered the artificial disc replacement procedure in 2000 and is furthering the practice by helping with the FDA trial of TFAS and other clinical trials.

About TFAS

TFAS(R) is used to treat spinal stenosis, which is the degenerative narrowing of the spaces in the spine that can lead to spinal cord or nerve root compression and causes the pain. The device has the potential to stabilize the affected vertebrae without rigidly fusing the joint or removing the intervertebral disc, allowing the patient to maintain a quality of motion similar to the patient's natural range of motion before stenosis. The TFAS surgical procedure includes removal of the degenerative bone and/or tissue that compresses the spinal cord and nerve roots that are causing lower back and leg pain. Specifically, TFAS replaces the degenerated facet joints with an implant that is affixed to the affected vertebrae and designed to restore the natural motion of the surgically removed facet joints and spinal ligaments.

About Texas Back Institute

Texas Back Institute, one of the largest freestanding spine multispecialty clinics in the United States, was established in 1978 and provides comprehensive medical care for back and neck pain. Texas Back Institute is a back care leader specializing in spinal arthroplasty, minimally invasive spine surgery, spinal deformation and spinal oncology care. As an academic health care organization, Texas Back Institute has trained hundreds of physicians, scientists and allied health professionals. Its research institution employs state-of-the-art technology and is involved in the most clinical trials, including artificial discs. Texas Back Institute's professional staff includes board-certified spine surgeons, general surgeons, internists, chiropractors, physiatrists, pain specialists, exercise physiologists, and a team of physical and occupational therapists. Texas Back Institute's main clinic is in Plano, with locations in Denton, Fort Worth, Greenville, McKinney, Rockwall, Trophy Club and Wichita Falls, Texas, and Phoenix, Arizona. For more information, visit http://www.texasback.com.


'/>"/>
SOURCE Texas Back Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
2. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
3. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
4. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
5. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
6. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
7. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
8. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
9. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
10. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
11. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017  Tarix Orphan ... Administration has granted a Rare Pediatric Disease (RPD) designation ... of Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic ... RDEB and treatment is limited to supportive care. ... the Orphan Drug Designation previously granted by the FDA ...
Breaking Medicine Technology:
(Date:1/18/2017)... VA (PRWEB) , ... January 18, 2017 , ... Floundering ... American Heart Month and the perfect time for a reset. The U.S. Apple Association ... studies to combat many of the factors that contribute to heart disease. , The ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a point of difference. Eden Activewear is a stand-out company for several differences ... exclusively online and only manufacture on demand, this is called 'Agile' manufacturing - ...
(Date:1/17/2017)... ... January 17, 2017 , ... SunView Software’s Service Smart ... Innovation of the Year. , Each year, Pink Elephant recognizes a new ... approach to address a specific business problem or opportunity. The award highlights original innovations ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Palm Desert, is opening a new office in San Clemente, California this month. ... (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression impacts ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... SightMD – will lecture to primary eye care practitioners on the latest breakthroughs ... the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, ...
Breaking Medicine News(10 mins):